Furthermore, utilizing Ingenuity Pathway Analysis (IPA), the interleukin-2 (IL-2) pathway emerges as a crucial modulator of both epigenomic and transcriptomic changes in blood cell development and function, which are instrumental in the pathogenesis of BPD. Here, IL2 is linked to bronchopulmonary dysplasia.